Despite this controversy, the present results showing that anti-PD-1 and anti-PD-L1 antibodies restore cytokine production and prevent apoptosis in immune cells from patients with sepsis are highly consistent with these animal studies and underscore their potential efficacy in clinical sepsis. This evidence concerns the gene PDCD1 and Sepsis.